PCMI
SRGA

Paradigm Capital Management Inc’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Paradigm Capital Management Inc’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,667
Closed -$308K – 160
2020
Q3 		$308K Sell
5,667
-157,649
-97% -$12.1M 0.03% 135
2020
Q2 		$15.6M Sell
163,316
-41,260
-20% -$3.07M 1.43% 26
2020
Q1 		$10.5M Buy
204,576
+3,767
+2% +$394K 1.27% 26
2019
Q4 		$16.5M Buy
200,809
+120
+0.1% +$8.41K 1.27% 26
2019
Q3 		$17.2M Buy
200,689
+1,067
+0.5% +$114K 1.54% 23
2019
Q2 		$25.5M Buy
199,622
+2,493
+1% +$359K 2.32% 11
2019
Q1 		$35.5M Sell
197,129
-13,640
-6% -$1.97M 3.12% 6
2018
Q4 		$23.4M Buy
210,769
+3,987
+2% +$519K 2.3% 13
2018
Q3 		$27.9M Buy
206,782
+9,111
+5% +$1.26M 2.2% 14
2018
Q2 		$27.3M Hold
197,671
– – 2.2% 14
2018
Q1 		$27.3M Sell
197,671
-3
-0% -$408 2.31% 10
2017
Q4 		$24.3M Buy
197,674
+4,368
+2% +$600K 2.08% 16
2017
Q3 		$26.4M Buy
193,306
+3,567
+2% +$538K 2.29% 10
2017
Q2 		$33.3M Sell
189,739
-4,703
-2% -$669K 2.99% 4
2017
Q1 		$23.3M Buy
194,442
+6,940
+4% +$722K 2.2% 14
2016
Q4 		$18.3M Buy
187,502
+11,884
+7% +$1.09M 1.78% 19
2016
Q3 		$16.5M Buy
175,618
+6,081
+4% +$610K 1.73% 18
2016
Q2 		$18.3M Buy
169,537
+14,184
+9% +$1.66M 2.23% 11
2016
Q1 		$18.6M Buy
155,353
+7,413
+5% +$779K 2.17% 12
2015
Q4 		$17.6M Buy
147,940
+21,949
+17% +$2.83M 1.96% 13
2015
Q3 		$21.5M Buy
125,991
+2,177
+2% +$417K 2.61% 5
2015
Q2 		$24M Sell
123,814
-20,656
-14% -$3.83M 2.48% 7
2015
Q1 		$21.4M Sell
144,470
-2,550
-2% -$388K 2.21% 9
2014
Q4 		$22.9M Sell
147,020
-14,667
-9% -$2.11M 2.26% 6
2014
Q3 		$23.2M Sell
161,687
-390
-0.2% -$56.5K 1.93% 5
2014
Q2 		$21.2M Buy
162,077
+1,300
+0.8% +$165K 1.57% 13
2014
Q1 		$19.7M Sell
160,777
-21,793
-12% -$2.36M 1.42% 16
2013
Q4 		$19.4M Sell
182,570
-4,283
-2% -$416K 1.17% 21
2013
Q3 		$21M Buy
186,853
+263
+0.1% +$29.8K 1.27% 18
2013
Q2 		$21M Buy
+186,590
New +$22.8M 0.98% 25

Other funds holding SRGA

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Paradigm Capital Management Inc's SRGA Position: Q4 2020 in Review

Paradigm Capital Management Inc sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2020, closing a stake of 5,667 shares — an estimated $308K sold.

Paradigm Capital Management Inc first reported a position in SRGA in Q2 2013 and held it in 30 quarters. The position peaked at $35.5M in Q1 2019. 96 funds tracked by Wall St. Rank hold SRGA as of Q4 2020.

  • Paradigm Capital Management Inc reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Paradigm Capital Management Inc sold 5,667 Surgalign Holdings, Inc. Common Stock shares in Q4 2020, an estimated $308K.
  • Paradigm Capital Management Inc first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 30 quarters.
  • Paradigm Capital Management Inc's Surgalign Holdings, Inc. Common Stock position peaked at $35.5M in Q1 2019.
  • 96 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2020.

Based on Paradigm Capital Management Inc's 13F filing for Q4 2020, filed 20 Jan 2021.